GlassScriptPhysician profile
Larry H Gaston
NPI 1083623979
$26,954.58
in general payments reported to CMS, 2019-2025
36 companies · $4,273 in 2025
The $4,273 reported for 2025 was more than what 89% of Dermatology providers received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,473 · 2020: $2,888 · 2021: $3,759 · 2022: $3,279 · 2023: $4,059 · 2024: $4,224 · 2025: $4,273.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $12K · Consulting Fee: $350 · Education: $280.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $11,925.42 |
| Consulting Fee | $350.00 |
| Education | $280.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $4,082.30 | 2019-2025 | |
| Novartis Pharmaceuticals Corporation | $3,179.77 | 2019-2025 | |
| Medimetriks Pharmaceuticals, INC. | $2,594.92 | 2019-2025 | Clindacin Etz, Neo-Synalar |
| Ucb, INC. | $2,263.68 | 2019-2025 | Bimzelx, Cimzia |
| Pfizer INC. | $1,757.32 | 2019-2025 | |
| Regeneron Healthcare Solutions, INC. | $1,582.94 | 2019-2025 | Dupixent |
| Janssen Biotech, INC. | $1,327.28 | 2019-2025 | Tremfya |
| Dermavant Sciences, INC. | $1,261.03 | 2023-2024 | Vtama |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $1,258.04 | 2019-2024 | Cabtreo, Arazlo |
| Sun Pharmaceutical Industries INC. | $1,183.07 | 2019-2025 | Winlevi, Absorica Ld, Ilumya |
| Lilly USA, LLC | $1,048.00 | 2019-2025 | Taltz, Olumiant, Ebglyss |
| Galderma Laboratories, L.P. | $1,013.95 | 2019-2025 | Nemluvio, Aklief |
| E.R. Squibb & Sons, L.L.C. | $871.78 | 2022-2025 | Sotyktu |
| Incyte Corporation | $595.50 | 2021-2025 | Opzelura |
| Genzyme Corporation | $567.70 | 2019-2025 |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dermira, INC. | $496.15 | 2019-2021 | |
| Leo Pharma INC. | $325.38 | 2019-2024 | Adbry |
| Amgen INC. | $226.09 | 2019-2023 | Otezla |
| Journey Medical Corporation | $174.83 | 2019-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $160.68 | 2023-2025 | Spevigo |
| Vyne Pharmaceuticals INC. | $143.71 | 2020-2021 | |
| Arcutis Biotherapeutics, INC. | $129.92 | 2023-2025 | Zoryve |
| Janssen Scientific Affairs, LLC | $125.00 | 2019 | |
| Organon LLC | $107.66 | 2025 | Vtama |
| Sanofi-Aventis U.S. LLC | $85.00 | 2024 | |
| Paratek Pharmaceuticals, INC. | $70.65 | 2022-2025 | Nuzyra |
| Strata Skin Sciences, INC. | $67.05 | 2019-2025 | Xtrac |
| Botanix Sb INC | $59.72 | 2025 | Sofdra |
| Prugen, INC. Pharmaceuticals | $42.22 | 2019 | |
| Taro Pharmaceuticals USA, INC. | $41.05 | 2019 | |
| Mayne Pharma Commercial LLC | $27.76 | 2019 | |
| Phadia US INC. | $24.78 | 2020 | |
| Celgene Corporation | $22.15 | 2019 | |
| Mission Pharmacal Company | $19.33 | 2020 | |
| Merck Sharp & Dohme LLC | $13.17 | 2019 | |
| Glenmark Therapeutics INC. | $5.00 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Larry Gaston listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.